Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structural biology and drug discovery.

Giovanna Scapin1

  • 1Department of Medicinal Chemistry, Merck & Co., Inc., Rahway, NJ 07065, USA. giovanna_scapin@merck.com

Current Pharmaceutical Design
|June 27, 2006
PubMed
Summary

Macromolecular crystallography now aids drug discovery by revealing protein-ligand interactions. Advances in technology enhance structure-based drug design (SBDD), leading to better, safer medicines.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biophysical trade-offs in antibody evolution are resolved by conformation-mediated epistasis.

bioRxiv : the preprint server for biology·2026
Same author

The Discovery of RP-2119: A Potent, Selective, and Orally Bioavailable Polθ ATPase Inhibitor.

Journal of medicinal chemistry·2025
Same author

Preclinical characterization of novel multi-client inhibitors of Sec61 with broad antitumor activity.

The Journal of pharmacology and experimental therapeutics·2025
Same author

Discovery of sulfone containing metallo-β-lactamase inhibitors with reduced bacterial cell efflux and histamine release issues.

Bioorganic & medicinal chemistry letters·2024
Same author

Cerastecin Inhibition of the Lipooligosaccharide Transporter MsbA to Combat <i>Acinetobacter baumannii</i>: From Screening Impurity to <i>In Vivo</i> Efficacy.

Journal of medicinal chemistry·2024
Same author

Mechanistic insights into a heterobifunctional degrader-induced PTPN2/N1 complex.

Communications chemistry·2024

Area of Science:

  • Biochemistry
  • Structural Biology
  • Pharmacology

Background:

  • Macromolecular crystallography is a key technique in pharmaceutical and biotechnology industries.
  • It provides high-resolution insights into protein-ligand interactions, crucial for drug development.

Purpose of the Study:

  • To review the evolution of macromolecular crystallography in drug discovery.
  • To illustrate how structural information is utilized across various stages of the drug discovery pipeline.

Main Methods:

  • High-throughput crystallization.
  • High-performance synchrotron beamlines.
  • Structural bioinformatics and computational chemistry.

Main Results:

  • Technological advancements have accelerated structure determination and structure-based drug design (SBDD).
  • Structural data is now integral to target selection and lead discovery, expanding beyond interaction analysis.

Conclusions:

  • Macromolecular crystallography has evolved into a versatile tool for modern drug discovery.
  • The methodology offers significant advantages despite being resource-intensive, driving innovation in pharmaceutical research.

Related Experiment Videos